BSG and neoplasm: Because CD147 is important for the growth, survival and invasion of tumor cells, anti-CD147 reagents, such as anti-CD147 antibodies, peptide fragments of CD147 and siRNAs directed to CD147 are being explored as anti-tumor therapeutics [14–16].